|
|
个人简介
毕业于浙江大学,主要从事先导化合物的靶向设计、合成和活性评价和先导化合物与靶点的分子动力学模拟研究。
学习和工作经历
1997.09-2001.06 温州师范学院 化学系 化学教育 理学学士
2001.09-2004.03 浙江大学 化学系 物理化学 理学硕士
2004.03-2007.03 浙江大学 化学系 化学生物学 理学博士
2007.06-2018.06 宁波大学 海洋学院 海洋药学系 副教授
2010.03-2010.10 中国科学院 上海药物所 交流访问
2013.01-2014.01 新加坡国立大学药学院 交流访问
2018.06-2023.07 宁波大学 食品与药学学院 副教授/系主任
2023.07-至今 宁波大学 博彩导航 副教授
近年发表的主要论文
1. Fang L, He S, Yin P, Wang N, Zhang B*, Jin H*. Design, synthesis, and structure –activity relationship studies of novel tryptamine derivatives as 5–HT1B receptor agonists. J Mol. Struct. 2022, 1265, 133320.
2. Liu Z, Jiang A, Wang Y, Xu P, Zhang Q, Wang Y, He S, Wang N*, Jin H*, Zhang B*. In silico, synthesis and anticancer evaluation of benzamide tryptamine derivatives as novel eEF2K inhibitors. Bioorg. Med. Chem. Lett. 2022, 67, 128759.
3. Zhang B, Zhang T, Zhang TY, Wang N*, He S, Wu B, Jin HX*. A Novel methoxybenzyl 5-nitroacridone derivative effectively triggers G1 cell cycle arrest in chronic myelogenous leukemia K562 cells by inhibiting CDK4/6-mediated phosphorylation of Rb. Int. J. Mol. Sci. 2020, 21(14),5077.
4. Xu P, Ding L*, Wei J, Li Q, Gui M, He X, Su D, He S, Jin H*. A new aquatic pathogen inhibitor produced by the marine fungus Aspergillus sp. LS116. Aquaculture. 2020, 520, 734670.
5. Zhang B, Dou Z, Xiong Z, Wang N*, He S, Yan X, Jin H*. Design, synthesis and biological research of novel N-phenylbenzamide-4-methylamine acridine derivatives as potential topoisomerase I/II and apoptosis-inducing agents, Bio.Med.Chem.Lett. 2019,29,126714.
6. Li W, Ding L*, Wang N, Xu J, Zhang W, Zhang B, He Shan, Wu B, Jin H*. Isolation and Characterization of Two New Metabolites from the Sponge-Derived Fungus Aspergillus sp. LS34 by OSMAC Approach. Mar Drugs. 2019,17,283.
7. 戴明权,金海晓*,严小军,整合素αvβ3结构与激活及其肿瘤靶向药物的研究进展,生物学杂志,2018,35(4):81-85.
8. Jin HX, Go ML, Yin P, Qiu XT, Zhu P, Yan XJ. Determining the functions of HIV-1 Tat and a second magnesium ion in the CDK9/cyclin T1 complex: a molecular dynamics simulation study. PLoS One.2015, 10(4):e0124673
9. Jin H, Nguyen T, Mei-Lin G. Acetylcholinesterase and Butyrylcholinesterase Inhibitory Properties of Functionalized Tetrahydroacri-dines and Related Analogs. Med chem, 2014, 4: 688-696.
10. Cai BQ, Jin HX*, Yan X, Zhu P, Hu G. 3D-QSAR and 3D-QSSR studies of Thieno [2,3-d]pyrimidin-4-yl Hydrazone analogues as CDK4 inhibitors by CoMFA analysis. Acta Pharmacologica Sinica.2014, 35(1):151-160
11. Huang Q$, Jin H$, Liu Q, Wu Q, Kang H, Cao Z, Zhu R.Proteochemometric modeling of the bioactivity spectra of HIV-1 protease inhibitors by introducing protein-ligand interaction fingerprint. PLoS One. 2012,7(7),e41698 (co-first author)
12. Jin HX, Zhang B, Jun YX, Xu JL, Tan VBC. Influences of phosphorylation on Thr14/Tyr15 in CDK5 in the presence of roscovitine/ATP and HHASPRK. Molecular Simulation, 2012,38(3):248-257
13. 金海晓,严小军,朱鹏,PKA酶及其抑制剂balanol的计算化学,化学进展,2010,Vol.22, 993-1001 2010.5 Computational Chemistry of protein kinase A and its inhibitor balanol
14. 金海晓,吴天星,严小军,蒋勇军,邹建卫,抑制剂BD2对PKA与PKC βII的抑制选择性研究,化学学报,2009,Vol.67, 1487-1491
15. Jin HX, Wu TX, Jiang YJ, Zou JW, Zhuang SL, Mao X, Yu QS, role of phosphorylated Thr-197 in the catalytic subunit of cAMP-dependent protein kinase, Journal of Molecular Structure:THEOCHEM 2007, 805,9-15
16. Jin HX, Wu TX, Jiang YJ, Zou JW, Zhuang SL, Mao X, Yu QS, Functional role of three water molecules buried within catalytic subunit of cAMP-dependent protein kinase, Journal of Molecular Structure:THEOCHEM 2007, 809,21-27
17. 金海晓,胡桂香,吴天星,商志才,邹建卫,俞庆森,药物水溶解度的QSAR研究和VolSurf参数,结构化学,2004,Vol.23, 452-458.
近年主持/参与的项目
1. 国家自然科学基金(20903058)
2. 宁波市自然科学基金(2010A610025)
3. 省创新团队子项目(2010R50029-3)
4. 宁波市科技局重大项目(2017C110026)
已获授权的发明专利
1. 一种色胺衍生物类化合物及其制备方法和用途,发明人:金海晓,何山,丁立建,张金荣,授权公告日:2015.08.12专利号:201310487187.8
2. 一种有机膦功能化的吡啶类离子液体及其制备方法,发明人:朱涛峰,梁洪泽,金海晓,胡可威,黄记有,黄飞隆,朱海峰,授权公告日:2016.01.06专利号:201210121891.7
3. 一种苯并呋喃类化合物及其制备方法和用途,发明人:丁立建,何山,张为艳,金海晓,王宁,崔巍,授权公告日:2022.12.06,专利号:ZL201910170042.2
著作编写
1.《化学化工软件应用教程》,胡桂香主编,卢运祥 金海晓副主编,化学工业出版社
学术兼职